From the common cold to MRSA, you will find a range of helpful tips and information here.
11 New Medications for Primary Care
Here: a quick look at newly approved agents for primary care that will soon be coming your way.
Postmarket Drug Safety Quiz: 8 Questions About Risk
Test your knowledge of the safety events that have occurred involving FDA-approved drugs since the turn of the century.
Post-Test on Hepatitis C in Primary Care
Take this brief quiz to see what you’ve learned about the challenges and opportunities of HCV management.
Hepatitis C Drugs Meet Resistance Issues
Resistance-associated variants limit the activity of some drugs, but HIV infection treatment may offer some guidance.
Hepatitis C: What If You Do Not Treat?
Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.
Newer Hepatitis C Drugs Mean Direct Action
The “modern era” of treatment features multiple DAAs that target specific steps within the HCV life cycle.
Medicaid Is Tight on Hepatitis C Drug Coverage
State Medicaid programs and private insurance companies have balked at providing these drugs to their insured customers. But the tide is turning.
Hepatitis C Report: What Tests to Order
Testing is recommended for the persons who are more likely to have the virus but not know it.
Hepatitis C Screening for High Risk Patients
Patients can be identified at earlier stages of disease, before serious liver damage, and have improved clinical outcomes.
Hepatitis C Report: Tuning in to a Silent Epidemic
Knowing the origin and causes could help clinicians better determine who to screen and treat.